Lucijanić, M., Galušić, D., Sorić, E., Sedinić, M., Ćubela, M., Huzjan Korunić, R. ... Kušec, R. (2021). Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology, 100. (4), 1105-1106. doi: 10.1007/s00277-020-04243-8
Lucijanić, Marko, et al. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology, vol. 100, br. 4, 2021, str. 1105-1106. https://doi.org/10.1007/s00277-020-04243-8
Lucijanić, Marko, Davor Galušić, Ena Sorić, Martina Sedinić, Marta Ćubela, Renata Huzjan Korunić, Vlatko Pejša i Rajko Kušec. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology 100, br. 4 (2021): 1105-1106. https://doi.org/10.1007/s00277-020-04243-8
Lucijanić, M., et al. (2021) 'Ruxolitinib treatment improves muscle mass in patients with myelofibrosis', Annals of Hematology, 100(4), str. 1105-1106. doi: 10.1007/s00277-020-04243-8
Lucijanić M, Galušić D, Sorić E, Sedinić M, Ćubela M, Huzjan Korunić R, i sur.. Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology [Internet]. 04.2021. [pristupljeno 06.12.2024.];100(4):1105-1106. doi: 10.1007/s00277-020-04243-8
M. Lucijanić, et al., "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis", Annals of Hematology, vol. 100, br. 4, str. 1105-1106, Travanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:268065. [Citirano: 06.12.2024.]